DcR2 抗体
TNFRSF10D 适用: 人, 猴 WB, ELISA, IHC, FACS, ICC, Neut 宿主: 小鼠 Monoclonal 6G7G1 unconjugated
TNFRSF10D 适用: 人, 小鼠 WB, ELISA, IHC, FACS, ICC, Neut 宿主: 小鼠 Monoclonal 6E5A9 unconjugated
DcR2 抗体 by 适用
Find DcR2 抗体 for a variety of species such as anti-Human DcR2, anti-Mouse DcR2, anti-Rat DcR2. The species listed below are among those available. Click on a link to go to the corresponding products.
DcR2 抗体 by 应用范围
Find DcR2 抗体 validated for a specific application such as WB, ELISA, FACS, IHC. Some of the available applications are listed below. Click on a link to go to the corresponding products.
DcR2 抗体 by 抗体来源
Find DcR2 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
DcR2 抗体 by 克隆形成能力
Find available monoclonal or polyclonal DcR2 抗体. Click on a link to go to the corresponding products.
DcR2 抗体 by 克隆
Find DcR2 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
Popular DcR2 抗体
- (4)
- (4)
- (4)
- (3)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
Latest Publications for our DcR2 抗体
: "Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells." in: PLoS ONE, Vol. 14, Issue 4, pp. e0214847, (2019) (PubMed).: "Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells." in: BMC cancer, Vol. 19, Issue 1, pp. 496, (2019) (PubMed).
: "Targeting of CD133+ Cancer Stem Cells by Mesenchymal Stem Cell Expressing TRAIL Reveals a Prospective Role of Apoptotic Gene Regulation in Non-Small Cell Lung Cancer." in: Cancers, Vol. 11, Issue 9, (2019) (PubMed).
: "Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells." in: Cell death & disease, Vol. 8, Issue 8, pp. e3025, (2018) (PubMed).
: "Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps." in: PLoS ONE, Vol. 13, Issue 6, pp. e0198203, (2018) (PubMed).
: "TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis." in: Scientific reports, Vol. 7, Issue 1, pp. 5514, (2017) (PubMed).
: "Targeting Apoptotic Activity Against Prostate Cancer Stem Cells." in: International journal of molecular sciences, Vol. 18, Issue 8, (2017) (PubMed).
: "Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells." in: Stem cell research & therapy, Vol. 8, Issue 1, pp. 201, (2017) (PubMed).
: "The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2." in: Molecular cell, Vol. 65, Issue 4, pp. 730-742.e5, (2017) (PubMed).
: "Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 21, Issue 23, pp. 5338-48, (2015) (PubMed).
Aliases for DcR2 抗体
TNF receptor superfamily member 10d (TNFRSF10D) 抗体tumor necrosis factor receptor superfamily member 10D (LOC716901) 抗体
CD264 抗体
DCR2 抗体
TNFRSF10D 抗体
TRAIL-R4 抗体
TRAILR4 抗体
TRUNDD 抗体
